1,3,4,5-tetrahydro-7,8-dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylimino)propyl)-2H-3-benzazepin-2-one hydrochloride,
UL-FS 49,
UL-FS-49,
zatebradine,
zatebradine hydrochloride,
Zatebradine,
85175-67-3,
Zatebradine [INN],
Zatebradinum [INN-Latin],
Zatebradina [INN-Spanish],
UNII-TV27RY5876,
UL-FS-49,
CHEMBL69679,
C26H36N2O5,
TV27RY5876,
UL-FS49,
Zatebradina,
Zatebradinum,
3-(3-((3,4-Dimethoxyphenethyl)methylamino)propyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-2H-3-benzazepin-2-one,
3-[3-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one,
Zatabradine,
SCHEMBL295751,
AC1L23O2,
GTPL2358,
DTXSID1048413,
CHEBI:93613,
KEDQCFRVSHYKLR-UHFFFAOYSA-N,
ZINC538544,
BCP16190,
BDBM50326988,
HY-13422A,
MFCD00867014,
AKOS030213235,
CS-3620,
1,3,4,5-tetrahydro-7,8-dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylimino)propyl)-2H-3-benzazepin-2-one hydrochloride,
LS-177852,
FT-0729624,
BRD-K92446736-003-01-4,
1-[7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-on-3-yl]-3-[N-methyl-N-(2-{3,4-dimethoxy-phenyl}-ethyl)-amino]-propane,
1-[7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-on-3-yl]-3-[N-methyl-N-(2-{3,4-dimethoxy-phenyl}ethyl)-amino]-propane,
3-(3-{[2-(3,4-Dimethoxy-phenyl)-ethyl]-methyl-amino}-propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-benzo[d]azepin-2-one,
Zatebradine hydrochloride,
D0NR3V,
UL-FS 49,
UL-FS-49CL,
CID65637,
C26-H36-N2-O5,
C043636,
2H-3-Benzazepin-2-one, 3-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-,
91940-87-3,